News
Press Releases
Mammotome Secures FDA Clearance for Industry-First, In‑Room MR Vacuum‑Assisted Breast Biopsy System and New HydroMARK™ Plus MR Biopsy Site Markers
Mammotome announces FDA Clearance of two innovations for MR-guided breast biopsy: the Mammotome Prima™ MR Dual Vacuum-Assisted Breast Biopsy System and the HydroMARK™ Plus Breast Biopsy Site Marker for MR.
Sirius Medical and Mammotome Announce Health Canada Approval for The Pintuition® System, Expanding Access Across the Country
Mammotome and Sirius Medical announce Health Canada approval for the Pintuition® System.
Mammotome and Sirius Medical Expand Partnership for Distribution of the Pintuition® System Across Italy and Poland
Mammotome and Sirius Medical are proud to announce an exclusive distribution agreement for the Pintuition® System in Italy and Poland.
Mammotome Celebrates 30 Years of Advancing Breast Care Innovation and Impact
Mammotome proudly celebrates its 30th anniversary – marking three decades of innovation, compassion and unwavering commitment to improving outcomes for patients and clinicians worldwide.
Mammotome Advances Surgical Precision with 10mm Probes for the Neoprobe® Gamma Detection System
Mammotome is proud to unveil exciting enhancements to its trusted Neoprobe® Gamma Detection System (GDS).
Mammotome and Sirius Medical Partner to Distribute Sirius Pintuition® Across the United States and Germany
Mammotome and Sirius Medical are proud to announce an exclusive distribution agreement for the United States and Germany.
The Mammotome Revolve™ Dual Vacuum-Assisted Breast Biopsy System Has Been Refined
Mammotome is thrilled to unveil enhancements to the Mammotome Revolve™ biopsy system, a device that is a cornerstone in procedural efficiency and tissue quality in the breast care suite.
Mammotome Expands the HydroMARK™ Plus Breast Biopsy Site Marker Portfolio, an Innovation Addressing Tissue Marker Displacement
Mammotome is excited to announce an addition to the recently launched HydroMARK™ Plus Breast Biopsy Site Marker line.
Mammotome Launches the LumiMARK™ Biopsy Site Marker, a Tissue Marker Distinct from Every Angle
Mammotome announced the 510(k) clearance for the novel LumiMARK™ Biopsy Site Marker, a tissue marker line designed with visibility top of mind.
Mammotome Launches the HydroMARK™ Plus Breast Biopsy Site Marker, an Innovation for Tissue Marker Displacement
Mammotome announced the launch of an innovative new HydroMARK™ Plus Breast Biopsy Site Marker designed to enhance ultrasound visibility, improve ease
Mammotome Announces the Launch of the Mammotome DualCore™ Dual Stage Core Biopsy System
Mammotome is excited to announce the launch of the Mammotome DualCore™ biopsy system, the company’s first dual stage core biopsy instrument.
New product line extension for the HydroMARK™ breast biopsy site markers
Mammotome is pleased to announce a new product line of flexible HydroMARK™ Breast Biopsy Site Marker applicators designed to make the clinician’s user experience easier and more intuitive.
Mammotome News
New ASBrS and SBI Guidelines for Vacuum-Assisted Excision for Benign Breast Lesions
ASBrS and SBI have released updated clinical guidelines for the management of benign breast disease.
Mammotome Initiatives to Reduce Our Environmental Footprint
In addition to improving breast care for patients worldwide, Mammotome is on a mission to reduce its environmental impact. Continue reading to learn about several